July 2025 Price Concessions 2nd Update
The Department of Health and Social Care (DHSC) has today (25/07/2025) confirmed the following list of price concessions for July 2025:
| Drug | Pack size | Price concession |
| Amiodarone 200mg tablets | 28 | £5.39 |
| Ascorbic acid 500mg tablets | 28 | £42.99 |
| Bumetanide 1mg tablets | 28 | £2.99 |
| Desogestrel 75microgram tablets | 84 | £2.70 |
| Esomeprazole 40mg gastro-resistant capsules | 28 | £2.80 |
| Fenofibrate micronised 267mg capsules | 28 | £2.82 |
| Piroxicam 0.5% gel | 60 | £1.87 |
| Risperidone 500microgram orodispersible tablets sugar free | 28 | £6.46 |
| Sitagliptin 25mg tablets | 28 | £5.76 |
| Ursodeoxycholic acid 150mg tablets | 60 | £73.99 |
| Venlafaxine 300mg modified-release tablets | 30 | £42.24 |
Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.
Notes
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
Next Steps
Pharmacies should continue to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on our website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, submit further price concession applications to DHSC. Any prices granted by DHSC, will only be agreed by Community Pharmacy England if they are supported by the reports received by our team.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions)
